374 related articles for article (PubMed ID: 11344085)
1. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.
Langen RC; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2001 May; 15(7):1169-80. PubMed ID: 11344085
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes.
Li YP; Reid MB
Am J Physiol Regul Integr Comp Physiol; 2000 Oct; 279(4):R1165-70. PubMed ID: 11003979
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways.
Langen RC; Schols AM; Kelders MC; Van Der Velden JL; Wouters EF; Janssen-Heininger YM
Am J Physiol Cell Physiol; 2002 Sep; 283(3):C714-21. PubMed ID: 12176728
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α.
Ono Y; Sakamoto K
PLoS One; 2017; 12(7):e0182040. PubMed ID: 28742154
[TBL] [Abstract][Full Text] [Related]
6. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
7. Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.
Ardite E; Barbera JA; Roca J; Fernández-Checa JC
Am J Pathol; 2004 Sep; 165(3):719-28. PubMed ID: 15331397
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
Guttridge DC; Mayo MW; Madrid LV; Wang CY; Baldwin AS
Science; 2000 Sep; 289(5488):2363-6. PubMed ID: 11009425
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.
Dogra C; Changotra H; Mohan S; Kumar A
J Biol Chem; 2006 Apr; 281(15):10327-36. PubMed ID: 16461349
[TBL] [Abstract][Full Text] [Related]
10. TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway.
Zhao Q; Yang ST; Wang JJ; Zhou J; Xing SS; Shen CC; Wang XX; Yue YX; Song J; Chen M; Wei YY; Zhou QP; Dai T; Song YH
Biochem Biophys Res Commun; 2015 Mar; 458(4):790-5. PubMed ID: 25686491
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of truncated IkappaBalpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells.
Obara H; Takayanagi A; Hirahashi J; Tanaka K; Wakabayashi G; Matsumoto K; Shimazu M; Shimizu N; Kitajima M
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2198-204. PubMed ID: 11031204
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria mediate tumor necrosis factor-alpha/NF-kappaB signaling in skeletal muscle myotubes.
Li YP; Atkins CM; Sweatt JD; Reid MB
Antioxid Redox Signal; 1999; 1(1):97-104. PubMed ID: 11225736
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity.
Tolosa L; Morlá M; Iglesias A; Busquets X; Lladó J; Olmos G
Cell Signal; 2005 Nov; 17(11):1333-42. PubMed ID: 16125053
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha regulates myogenesis to inhibit differentiation and promote proliferation in satellite cells.
Shirakawa T; Rojasawasthien T; Inoue A; Matsubara T; Kawamoto T; Kokabu S
Biochem Biophys Res Commun; 2021 Nov; 580():35-40. PubMed ID: 34619550
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products.
Ladner KJ; Caligiuri MA; Guttridge DC
J Biol Chem; 2003 Jan; 278(4):2294-303. PubMed ID: 12431991
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression.
Natarajan K; Manna SK; Chaturvedi MM; Aggarwal BB
Arch Biochem Biophys; 1998 Apr; 352(1):59-70. PubMed ID: 9521814
[TBL] [Abstract][Full Text] [Related]
17. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6.
Baeza-Raja B; Muñoz-Cánoves P
Mol Biol Cell; 2004 Apr; 15(4):2013-26. PubMed ID: 14767066
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha.
Li YP; Schwartz RJ; Waddell ID; Holloway BR; Reid MB
FASEB J; 1998 Jul; 12(10):871-80. PubMed ID: 9657527
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumour necrosis factor alpha.
Han CW; Choi JH; Kim JM; Kim WY; Lee KY; Oh GT
Rheumatology (Oxford); 2001 Mar; 40(3):267-73. PubMed ID: 11285373
[TBL] [Abstract][Full Text] [Related]
20. PPARγ as a molecular target of EPA anti-inflammatory activity during TNF-α-impaired skeletal muscle cell differentiation.
Magee P; Pearson S; Whittingham-Dowd J; Allen J
J Nutr Biochem; 2012 Nov; 23(11):1440-8. PubMed ID: 22305406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
